Covis initiates U.S. asthma inhaler study for COVID-19

Unlisted Covis Pharma B.V. started a late-stage U.S. randomized trial of its asthma drug Alvesco in non-hospitalized patients with symptomatic COVID-19, hoping the inhaled drug treats symptoms and limits viral replication.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news